BioCentury | Dec 15, 2017
Company News

Allergan to acquire Repros

...includes SPRM Proellex telapristone acetate to treat symptoms associated with uterine fibroids and endometriosis, and enclomiphene citrate...
...Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Allergan plc (NYSE:AGN), Dublin, Ireland Business: Endocrine/Metabolic, Genitourinary Jennie Walters enclomiphene citrate Proellex Proellex-V Allergan...
BioCentury | Oct 10, 2016
Clinical News

Enclomiphene citrate regulatory update

...see BioCentury, Dec. 7, 2015). Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Product: Enclomiphene citrate (formerly Androxal...
BioCentury | Sep 19, 2016
Clinical News

Enclomiphene citrate regulatory update

...see BioCentury, Dec. 7, 2015). Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Product: Enclomiphene citrate (formerly Androxal...
BioCentury | Sep 5, 2016
Clinical News

Enclomiphene citrate: Interim Phase II data

...see BioCentury, Dec. 7, 2015). Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Product: Enclomiphene citrate (formerly Androxal...
BioCentury | Feb 22, 2016
Clinical News

Enclomiphene citrate: Completed Phase II enrollment

...see BioCentury, Dec. 7, 2015). Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Product: Enclomiphene citrate (formerly Androxal...
BioCentury | Dec 7, 2015
Clinical News

Enclomiphene citrate regulatory update

...next steps for the product. Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Product: Enclomiphene citrate (formerly Androxal...
BioCentury | Nov 9, 2015
Clinical News

Enclomiphene citrate regulatory update

...the trans-isomer of clomiphene citrate. Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Product: Enclomiphene citrate (formerly Androxal...
BioCentury | Oct 22, 2015
Distillery Therapeutics

Therapeutics: Undecaprenyl diphosphate synthase (uppS)

...could include testing clomiphene in mouse models of S. aureus infection. Repros Therapeutics Inc. has enclomiphene citrate...
BioCentury | Oct 5, 2015
Finance

Event planner

...Submit BLA YE15 Relypsa Inc. (NASDAQ:RLYP) Patiromer Hyperkalemia PDUFA date 10/21/15 Repros Therapeutics Inc. (NASDAQ:RPRX) Enclomiphene citrate...
BioCentury | Jul 30, 2015
Distillery Therapeutics

Therapeutics: Calcium channel; serotonin (5-HT) transporter (SLC6A4; SERT); estrogen receptor; androgen receptor

...that targets SLC6A4 , to treat anxiety, bipolar disorder and depression. Repros Therapeutics Inc. has enclomiphene citrate...
Items per page:
1 - 10 of 95